GGrantIndex
← Leaderboards

Julia R Koehler

Whitehead Institute For Biomedical Res

$7,967,257
Attributed
$9,125,699
Total exposure
12
Grants
11
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.1M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$9,125,699 · 12

By mechanism

R01$4,055,005 · 2
R21$3,076,830 · 7
R33$1,428,880 · 1
G08$436,464 · 1
K08$128,520 · 1

Top collaborators

Others in their field

Top investigators on “Candida Albicans

Research focus

Candida AlbicansGrowthSirolimusCellsVirulenceFungusAntifungal AgentsCandidaInfectionSignal TransductionResistanceHomologous GeneStressMycosesCell WallGeneticBiologicalPharmaceutical PreparationsCandidiasisResponseCessation Of LifePathogenic FungusScreeningSignal Pathway

Grant awards (28)

C. albicans cell wall stress responses and TOR signaling$489,500
R21 · FY2025 · AI · contact PI
Candida albicans Target of Rapamycin in oxidative stress responses$258,990
R21 · FY2025 · AI · contact PI
Compounds that block a novel Candida albicans target$465,623
R33 · FY2023 · AI · contact PI
Inhibiting sequential biosynthetic steps of a fungal-specific organelle$445,444
R01 · FY2023 · AI · contact PI
Compounds that block a novel Candida albicans target$476,339
R33 · FY2022 · AI · contact PI
Inhibiting sequential biosynthetic steps of a fungal-specific organelle$450,754
R01 · FY2022 · AI · contact PI
Compounds that block a novel Candida albicans target$486,918
R33 · FY2021 · AI · contact PI
Inhibiting sequential biosynthetic steps of a fungal-specific organelle$473,764
R01 · FY2021 · AI · contact PI
Bridging Neglect: improved access to high-quality heart health information and care for communities at risk of Chagas disease$145,488
G08 · FY2021 · LM · contact PI
Inhibiting sequential biosynthetic steps of a fungal-specific organelle$510,459
R01 · FY2020 · AI · contact PI
Compounds that block a novel Candida albicans target$220,352
R21 · FY2020 · AI · contact PI
Bridging Neglect: improved access to high-quality heart health information and care for communities at risk of Chagas disease$145,488
G08 · FY2020 · LM · contact PI
Compounds that block a novel Candida albicans target$260,110
R21 · FY2019 · AI · contact PI
Role of Candida albicans phosphate transport in cell wall maintenance and echinocandin tolerance$221,250
R21 · FY2019 · AI · contact PI
Bridging Neglect: improved access to high-quality heart health information and care for communities at risk of Chagas disease$145,488
G08 · FY2019 · LM · contact PI
Role of Candida albicans phosphate transport in cell wall maintenance and echinocandin tolerance$265,500
R21 · FY2018 · AI · contact PI
The opportunist Candida albicans: yeast proliferation and nutritional signaling$442,500
R01 · FY2017 · AI · contact PI
The opportunist Candida albicans: yeast proliferation and nutritional signaling$442,500
R01 · FY2016 · AI · contact PI
The opportunist Candida albicans: yeast proliferation and nutritional signaling$440,417
R01 · FY2015 · AI · contact PI
The opportunist Candida albicans: yeast proliferation and nutritional signaling$437,917
R01 · FY2014 · AI · contact PI
The opportunist Candida albicans: yeast proliferation and nutritional signaling$411,250
R01 · FY2013 · AI · contact PI
New elements of the Target of Rapamycin pathway in Candida albicans$217,500
R21 · FY2012 · AI · contact PI
New elements of the Target of Rapamycin pathway in Candida albicans$260,000
R21 · FY2011 · AI · contact PI
Hypha-to-yeast morphogenetic step in C. albicans$206,286
R21 · FY2006 · AI · contact PI
Echinocandin resistant & hypersensitive C. albicans$197,742
R21 · FY2006 · AI · contact PI
Hypha-to-yeast morphogenetic step in C. albicans$245,900
R21 · FY2005 · AI
Echinocandin resistant &hypersensitive C. albicans$233,700
R21 · FY2005 · AI
MODELS OF CANDIDA ALBICANS--HOST INTERACTIONS$128,520
K08 · FY2000 · AI